Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden
Leukemia
.
2025 May;39(5):1256-1259.
doi: 10.1038/s41375-025-02573-y.
Epub 2025 Mar 26.
Authors
Mats Jerkeman
1
,
Karin Mellgren
2
,
Kristina Sonnevi
3
,
Mikael Lisak
2
,
Ingemar Lagerlöf
4
,
Balazs Kapas
5
,
Hanna Sjölund
6
,
Jacek Toporski
3
,
Hans Hagberg
7
,
Stephan Mielke
#
8
,
Gunilla Enblad
#
7
Affiliations
1
Skåne University Hospital and Lund University, Lund, Sweden. Mats.jerkeman@med.lu.se.
2
Sahlgrenska University Hospital, Gothenburg, Sweden.
3
Karolinska University Hospital, Stockholm, Sweden.
4
Linköping University Hospital, Linköping, Sweden.
5
Skåne University Hospital, Lund, Sweden.
6
Karolinska Institutet, Stockholm, Sweden.
7
Uppsala University Hospital, Uppsala, Sweden.
8
Karolinska Institutet and University Hospital, Stockholm, Sweden.
#
Contributed equally.
PMID:
40140632
PMCID:
PMC12055569
DOI:
10.1038/s41375-025-02573-y
No abstract available